Market Overview

Benzinga's Top Initiations

Related CLDX
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine
Encouraging Pre-Clinical Data from Celldex - Analyst Blog
Related BFAM
What Falling Estimates & Price Mean for Bridgepoint Education (BPI) - Tale of the Tape
UPDATE: Bank of America Reiterates on Bright Horizons Family Solutions as Organic Growth Accelerates in 4Q

Analysts at Leerink initiated coverage on shares of Celldex Therapeutics (NASDAQ: CLDX) with an “outperform” rating. The target price range for Celldex is set to $18. Celldex's shares closed at $10.71 yesterday.

Credit Suisse initiated coverage on shares of Bright Horizons Family Solutions LLC (NYSE: BFAM) with an “outperform” rating. The target price for Bright Horizons is set to $35. Bright Horizons' stock closed at $28.35 yesterday.

RBC Capital initiated coverage on shares of Walter Energy (NYSE: WLT) with a “sector perform” rating. The target price for Walter Energy is set to $34. Walter Energy's shares closed at $29.76 yesterday.

Analysts at Roth Capital initiated coverage on shares of Cytori Therapeutics (NASDAQ: CYTX) with a “buy” rating. The target price for Cytori Therapeutics is set to $8. Cytori Therapeutics' shares closed at $2.69 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Most Popular

Related Articles (CLDX + BFAM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free